ELAN
Price
$19.61
Change
+$0.69 (+3.65%)
Updated
Sep 26 closing price
Capitalization
9.74B
44 days until earnings call
PCRX
Price
$25.24
Change
-$0.41 (-1.60%)
Updated
Sep 26 closing price
Capitalization
1.13B
32 days until earnings call
Interact to see
Advertisement

ELAN vs PCRX

Header iconELAN vs PCRX Comparison
Open Charts ELAN vs PCRXBanner chart's image
Elanco Animal Health
Price$19.61
Change+$0.69 (+3.65%)
Volume$5.01M
Capitalization9.74B
Pacira BioSciences
Price$25.24
Change-$0.41 (-1.60%)
Volume$474.41K
Capitalization1.13B
ELAN vs PCRX Comparison Chart in %
Loading...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELAN vs. PCRX commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a Buy and PCRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (ELAN: $19.61 vs. PCRX: $25.24)
Brand notoriety: ELAN: Notable vs. PCRX: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ELAN: 63% vs. PCRX: 68%
Market capitalization -- ELAN: $9.74B vs. PCRX: $1.13B
ELAN [@Pharmaceuticals: Generic] is valued at $9.74B. PCRX’s [@Pharmaceuticals: Generic] market capitalization is $1.13B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 0 FA rating(s) are green whilePCRX’s FA Score has 0 green FA rating(s).

  • ELAN’s FA Score: 0 green, 5 red.
  • PCRX’s FA Score: 0 green, 5 red.
According to our system of comparison, PCRX is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 3 TA indicator(s) are bullish while PCRX’s TA Score has 4 bullish TA indicator(s).

  • ELAN’s TA Score: 3 bullish, 5 bearish.
  • PCRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PCRX is a better buy in the short-term than ELAN.

Price Growth

ELAN (@Pharmaceuticals: Generic) experienced а +2.14% price change this week, while PCRX (@Pharmaceuticals: Generic) price change was -5.33% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

ELAN is expected to report earnings on Nov 11, 2025.

PCRX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELAN($9.74B) has a higher market cap than PCRX($1.13B). ELAN has higher P/E ratio than PCRX: ELAN (22.28) vs PCRX (13.04). ELAN YTD gains are higher at: 61.932 vs. PCRX (33.970). ELAN has higher annual earnings (EBITDA): 1.45B vs. PCRX (-1.3M). ELAN has more cash in the bank: 539M vs. PCRX (446M). PCRX has less debt than ELAN: PCRX (631M) vs ELAN (4.21B). ELAN has higher revenues than PCRX: ELAN (4.48B) vs PCRX (706M).
ELANPCRXELAN / PCRX
Capitalization9.74B1.13B859%
EBITDA1.45B-1.3M-111,376%
Gain YTD61.93233.970182%
P/E Ratio22.2813.04171%
Revenue4.48B706M635%
Total Cash539M446M121%
Total Debt4.21B631M667%
FUNDAMENTALS RATINGS
ELAN vs PCRX: Fundamental Ratings
ELAN
PCRX
OUTLOOK RATING
1..100
872
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7995
PRICE GROWTH RATING
1..100
3948
P/E GROWTH RATING
1..100
87100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PCRX's Valuation (56) in the Pharmaceuticals Other industry is somewhat better than the same rating for ELAN (93) in the Agricultural Commodities Or Milling industry. This means that PCRX’s stock grew somewhat faster than ELAN’s over the last 12 months.

PCRX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that PCRX’s stock grew similarly to ELAN’s over the last 12 months.

ELAN's SMR Rating (79) in the Agricultural Commodities Or Milling industry is in the same range as PCRX (95) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew similarly to PCRX’s over the last 12 months.

ELAN's Price Growth Rating (39) in the Agricultural Commodities Or Milling industry is in the same range as PCRX (48) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew similarly to PCRX’s over the last 12 months.

ELAN's P/E Growth Rating (87) in the Agricultural Commodities Or Milling industry is in the same range as PCRX (100) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew similarly to PCRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELANPCRX
RSI
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
67%
Momentum
ODDS (%)
Bullish Trend 3 days ago
60%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
66%
Bearish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
67%
Bearish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 10 days ago
70%
Declines
ODDS (%)
Bearish Trend 6 days ago
73%
Bearish Trend 3 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
62%
Bullish Trend 3 days ago
76%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DDVAX14.380.19
+1.34%
Macquarie Value A
HGHIX37.090.47
+1.28%
Hartford Healthcare I
SRUIX15.410.08
+0.52%
Meeder Spectrum Institutional
HSWSX21.420.10
+0.47%
Hartford Schroders International Stk R4
FCAEX13.850.06
+0.44%
Fidelity Climate Action

ELAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with VTRS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then VTRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAN
1D Price
Change %
ELAN100%
+3.65%
VTRS - ELAN
53%
Loosely correlated
+0.32%
ZTS - ELAN
48%
Loosely correlated
+1.68%
PAHC - ELAN
39%
Loosely correlated
+2.02%
EBS - ELAN
38%
Loosely correlated
+1.95%
AMRX - ELAN
36%
Loosely correlated
+1.56%
More

PCRX and

Correlation & Price change

A.I.dvisor tells us that PCRX and ELAN have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PCRX and ELAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCRX
1D Price
Change %
PCRX100%
-1.60%
ELAN - PCRX
31%
Poorly correlated
+3.65%
ALKS - PCRX
31%
Poorly correlated
+2.80%
TEVA - PCRX
29%
Poorly correlated
-0.11%
ETON - PCRX
28%
Poorly correlated
+5.61%
COLL - PCRX
28%
Poorly correlated
-0.69%
More